针对多发性骨髓瘤的精密药物:转位的案例 (11;14)
Abdul-Hamid Bazarbachi1, Hervé Avet-Loiseau2, Jean-Luc Harousseau3
1Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
Cancer treatment reviews
|September 10, 2024
概括
在多发性骨髓瘤 (MM) 中的t(11;14) 转位显示出不同的预后意义. 虽然对一些新型药物反应较弱,但由于Bcl-2依赖,MM对venetoclax敏感.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 11;14) 转位是多发性骨髓瘤 (MM) 中常见的细胞遗传异常.
- 它的预后意义随着时间的推移而演变,从有利到中等风险.
- 这种亚型表现出独特的生物特征和治疗反应模式.
研究的目的:
- 审查目前关于多发性髓瘤中t(11;14) 转位的证据.
- 探索其不断变化的预后影响和生物特征.
- 讨论治疗敏感性和未来的治疗策略.
主要方法:
- 关于多发性髓瘤的现有研究的文献综述.
- 对检查预后意义和治疗反应的研究进行分析.
- 综合有关生物特征和治疗脆弱性的数据.
主要成果:
- 转位的t(11;14) 显示出可变的预后值.
- 这种MM亚型对蛋白酶体抑制剂和免疫调节药物反应较弱.
- t(11;14) 由于对Bcl-2的依赖,MM对venetoclax的敏感性增加.
结论:
- 需要使用基因组和形态学数据进一步分类t(11;14) MM.
- 改进的预测模型可以实现量身定制的治疗策略.
- 了解t(11;14) 生物学对于优化MM治疗至关重要.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K